Ceftazidime Sodium
Generic Name: ceftazidime sodium
Manufactured by PAI HOLDINGS PHARM. Dosage form: INJECTABLE. Route: INJECTION. Active ingredients: CEFTAZIDIME SODIUM (EQ 20MG BASE/ML). Application: NDA050634.
Overview
Manufactured by PAI HOLDINGS PHARM. Dosage form: INJECTABLE. Route: INJECTION. Active ingredients: CEFTAZIDIME SODIUM (EQ 20MG BASE/ML). Application: NDA050634.
Dosage
Available as injectable for injection use.
Related Medications
Mirikizumab-mrkz
mirikizumab-mrkz
Interleukin-23 Antagonist [EPC]
11 DESCRIPTION Mirikizumab-mrkz is a humanized immunoglobulin G4 (IgG4) variant monoclonal antibody that is directed against the p19 subunit of IL-23 and does not bind IL-12. Mirikizumab-mrkz is produced in Chinese Hamster Ovary (CHO) cells by recombinant DNA technology and it is composed of two identical light chain polypeptides and two identical heavy chain polypeptides with an overall molecular weight of approximately 147 kDa.
Formoterol Fumarate Dihydrate Cr
formoterol fumarate dihydrate cr
Dosage form: POWDER. Active ingredients: FORMOTEROL FUMARATE (100 kg/100kg). Category: BULK INGREDIENT.
Etanercept
etanercept
Dosage form: SOLUTION. Route: SUBCUTANEOUS. Active ingredients: ETANERCEPT (50 mg/mL). Category: BLA.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.